Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Coronaviruses
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
Su-Yeon Yua Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea
https://orcid.org/0000-0001-5488-5068View further author information
https://orcid.org/0000-0001-5488-5068View further author information, Dae-Hyup Koha Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0003-2720-4006View further author information
https://orcid.org/0000-0003-2720-4006View further author information, Miyoung Choia Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0002-2424-9965View further author information
https://orcid.org/0000-0002-2424-9965View further author information, Seungeun Ryooa Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0002-0604-5141View further author information
https://orcid.org/0000-0002-0604-5141View further author information, Kyungmin Huhb Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Koreahttps://orcid.org/0000-0002-5140-3964View further author information
https://orcid.org/0000-0002-5140-3964View further author information, Joon Sup Yeomc Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Koreahttps://orcid.org/0000-0001-8940-7170View further author information
https://orcid.org/0000-0001-8940-7170View further author information & Young Kyung Yoond Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0001-8435-935XView further author information
https://orcid.org/0000-0001-8435-935XView further author information show allRelated Research Data
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
Source:
Taylor & Francis
Linking provided by
